↓ Skip to main content

Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine

Overview of attention for article published in Cardiovascular Diabetology, September 2021
Altmetric Badge

Citations

dimensions_citation
13 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Renal hemodynamic effects differ between antidiabetic combination strategies: randomized controlled clinical trial comparing empagliflozin/linagliptin with metformin/insulin glargine
Published in
Cardiovascular Diabetology, September 2021
DOI 10.1186/s12933-021-01358-8
Pubmed ID
Authors

Christian Ott, Susanne Jung, Manuel Korn, Dennis Kannenkeril, Agnes Bosch, Julie Kolwelter, Kristina Striepe, Peter Bramlage, Mario Schiffer, Roland E. Schmieder

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 60 100%

Demographic breakdown

Readers by professional status Count As %
Researcher 6 10%
Student > Master 6 10%
Other 4 7%
Student > Ph. D. Student 3 5%
Student > Bachelor 3 5%
Other 13 22%
Unknown 25 42%
Readers by discipline Count As %
Medicine and Dentistry 19 32%
Nursing and Health Professions 5 8%
Biochemistry, Genetics and Molecular Biology 4 7%
Pharmacology, Toxicology and Pharmaceutical Science 2 3%
Environmental Science 1 2%
Other 4 7%
Unknown 25 42%